HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, tat, and cytokine apoptotic signaling Milan FialaWaldemar PolikJames Arthos Original Contributions Pages: 97 - 107
Pro-oxidant properties and cytotoxicity of AZT-Monophosphate and AZT I. Tong MakLucie F. NedelecWilliam B. Weglicki Original Contributions Pages: 109 - 115
Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation Valeria Y. HebertBrian L. CrenshawTammy R. Dugas Original Contributions Pages: 117 - 131
Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3′-azido-3′-deoxythymidine Dale M. WalkerMiriam C. PoirierVernon E. Walker Original Contributions Pages: 133 - 153
Phosphorylation of thymidine and AZT in heart mitochondria Edward E. McKeeAlice T. BentleyDelia Susan-Resiga Original Contributions Pages: 155 - 167
Cardiac pathologic effects of azidothymidine (AZT) in Mg-deficient mice I. Tong MakMaya G. GoldfarbChristian C. Haudenschild Original Contributions Pages: 169 - 177
Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapy Erika M. YoungRobert V. ConsidineMichael P. Dubé Original Contributions Pages: 179 - 186
Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART Jill E. LavigneWilliam T. ShearerCHAART Study Group Original Contributions Pages: 187 - 197
Vascular endothelial toxicity induced by HIV protease inhibitor Reshma S. BaligaCynthia LiuJohn A. Bauer Original Contributions Pages: 199 - 206